Electroluminescent TCC, C3dg and fB/Bb epitope assays for profiling complement cascade activation in vitro using an activated complement serum calibration standard.
van Vuuren, BJ; Bergseth, G; Mollnes, TE; et al.Shaw, AM
Date: 15 January 2014
Journal of Immunological Methods
Electroluminescent assays for epitopes on the complement components C3dg, terminal complement complex (TCC) and factor B/Bb (fB/Bb) have been developed with capture and detection antibodies to produce detection limits C3dg=91±9ng/mL, TCC=3±0.1ng/mL and fB=55.7±0.1ng/mL. The assay performance was assessed against a series of zymosan and ...
Electroluminescent assays for epitopes on the complement components C3dg, terminal complement complex (TCC) and factor B/Bb (fB/Bb) have been developed with capture and detection antibodies to produce detection limits C3dg=91±9ng/mL, TCC=3±0.1ng/mL and fB=55.7±0.1ng/mL. The assay performance was assessed against a series of zymosan and heat aggregated IgG (HAIgG) in vitro activations of complement using a calibrated activated complement serum (ACS) as calibration standard. The ACS standard was stable within 20% accuracy over a 6-month period with freeze-thaw cycles as required. Differential activation of the complement cascade was observed for TCC showing a pseudo-first order formation half-life of 3.5h after activation with zymosan. The C3dg activation fragment indicates a 10% total activation for both activation agents. The kinetic-epitope analysis for fB indicates that the capture epitope is on the fB/Bb protein fragment which can then become covered by the formation of C3bBb or C3bBbP complexes during the time course of the cascade.
College of Life and Environmental Sciences
Item views 0
Full item downloads 0
Showing items related by title, author, creator and subject.
Prosser, BE; Johnson, S; Roversi, P; et al. (Rockefeller University Press, 1 October 2007)Nearly 50 million people worldwide suffer from age-related macular degeneration (AMD), which causes severe loss of central vision. A single-nucleotide polymorphism in the gene for the complement regulator factor H (FH), ...
Time-course analysis of C3a and C5a quantifies the coupling between the upper and terminal Complement pathways in vitro Morad, HOJ; Belete, SC; Read, T; et al. (Elsevier for Association of Medical Laboratory Immunologists, 21 September 2015)An in vitro zymosan-activation of the Complement system, through the lectin and alternative pathways, was performed in pooled human serum over a 24h time-course. Activation was quantitatively monitored by measuring the ...
le Roux, S; Kelsey, D (2015)We report the results from a set of experiments conducted to test the e§ect of ambiguity on individual behaviour in games of strategic complements and strategic substitutes. We test whether subjectsíperception of ambiguity ...